Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?


Journal

Revista espanola de enfermedades digestivas
ISSN: 1130-0108
Titre abrégé: Rev Esp Enferm Dig
Pays: Spain
ID NLM: 9007566

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 24 11 2018
medline: 10 3 2020
entrez: 24 11 2018
Statut: ppublish

Résumé

hereditary diffuse gastric cancer (HDGC) is a recently reported hereditary cancer syndrome. Patients with suspected HDGC must be under surveillance via endoscopy and multiple biopsies. As an alternative, some studies suggest prophylactic gastrectomy (PG) for disease carriers. The goal of this article was to report our experience with a CDH1 mutation positive family who underwent PG. the index case was a 34-year-old female diagnosed with diffuse gastric adenocarcinoma and massive carcinomatosis. There was a family history of gastric adenocarcinoma in seven family members. A genetic study identified the c.1577G>A mutation, in exon 11 of the CDH1 gene via sequencing analysis. this mutation was also present in other six family members, who subsequently underwent prophylactic gastrectomy. The pathology study of resected gastric segments revealed multiple microscopic foci of adenocarcinoma in five of these individuals. These foci were not detected in the multiple endoscopies performed before surgery. we recommend prophylactic gastrectomy for CDH1 mutation carriers even in the absence of lesions during endoscopic screening.

Identifiants

pubmed: 30466290
doi: 10.17235/reed.2018.5831/2018
doi:

Substances chimiques

Antigens, CD 0
CDH1 protein, human 0
Cadherins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-192

Auteurs

Vicente Munitiz Ruiz (V)

Cirugía General, Hospital Clínico Universitario Virgen de la Arrixaca, España.

Pilar Jimeno (P)

Hospital Clínico Universitario Virgen de la Arrixaca.

David Ruiz de Angulo (D)

Hospital Clínico Universitario Virgen de la Arrixaca.

Ángeles Ortiz (Á)

Hospital Clínico Universitario Virgen de la Arrixaca.

Luisa F Martínez de Haro (LF)

Hospital Clínico Universitario Virgen de la Arrixaca.

Miguel Marín (M)

Hospital Clínico Universitario Virgen de la Arrixaca.

Pedro Cascales (P)

Hospital Clínico Universitario Virgen de la Arrixaca.

Gema Ruiz García (G)

Hospital Clínico Universitario Virgen de la Arrixaca.

Eduardo Ortiz Ruiz (E)

Hospital Clínico Universitario Virgen de la Arrixaca.

Pascual Parrilla (P)

Hospital Clínico Universitario Virgen de la Arrixaca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH